ASCRS Live: Centricity Vision and FDA clearing of ZeptoLink

Rob Thornhill, CEO of Centricity Vision, discussed the FDA clearing of ZeptoLink at the 2023 ASCRS annual meeting in San Diego.

Video transcript

Editor’s note: Transcript lightly edited for clarity.

Rob Thornhill:

Hi, my name is Rob Thornhill. I'm the CEO of Centricity Vision, speaking to you from San Diego, my hometown, at ASCRS 2023. We're here today to talk about the Zepto and ZeptoLink IOL positioning system, which are the first and only devices that create an instantaneous capsulotomy with precise 360 degree IOL overlap, making Zepto ideal for premium IOLs in complex cataract surgery that requires enhanced precision.

We're also excited this year at ASCRS to announce that the FDA just cleared our new technology called ZeptoLink. ZeptoLink seamlessly integrates our clinically proven Zepto technology with any phaco machine, which is used by all cataract urges. This seamless integration, streamlines cataract surgery, and saves time and space in the operating room. The ZeptoLink utilizes the irrigation and aspiration component of the phaco machine and allows the surgeon to control the entire procedure with the faecal foot pedal throughout the capsulotomy creation. In summary, ZeptoLink saves the surgeon time in the operating room. It also reduces the cost of care, especially compared to a laser system. And most importantly, it provides for long-term lens stability for the patient.